FCGR3A 158V/F polymorphism and response to frontline R-CHOP therapy in diffuse large B-cell lymphoma.

DNA and cell biology

Volumn 33, Issue 9, 2014, Pages 616-623

  Liu, Fen ^a   Ding, Huirong ^b   Jin, Xuan ^b   Ding, Ning ^b   Deng, Lijuan ^b   He, Yan ^b   Zhu, Jun ^b   Song, Yuqin ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FC RECEPTOR; FCGR3A PROTEIN, HUMAN; MONOCLONAL ANTIBODY; PREDNISONE; R CHOP PROTOCOL; R-CHOP PROTOCOL; VINCRISTINE;

AMINO ACID SUBSTITUTION; ARTICLE; GENETIC ASSOCIATION; GENETICS; HUMAN; LARGE CELL LYMPHOMA; META ANALYSIS; MORTALITY; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; TREATMENT OUTCOME;

AMINO ACID SUBSTITUTION; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; GENETIC ASSOCIATION STUDIES; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDNISONE; RECEPTORS, IGG; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 84908145988     PISSN: None     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2333     Document Type: Article

References (0)